NATURE’S SUNSHINE PRODUCTS, INC. Income Taxes Receivable, Current
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Income Taxes Receivable, Current of $5.74 million as of 2014-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Notes
us-gaap:IncomeTaxesReceivable · last filed 2014-11-06
- 2014-09-30: Income Taxes Receivable, Current $5.74M.
- 2014-06-30: Income Taxes Receivable, Current $8.45M.
- 2013-12-31: Income Taxes Receivable, Current $6.67M.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2014-09-30 | $5.74M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $8.45M 10-Q · filed 2014-08-07 |
| 2013-12-31 | $6.67M 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |